GUARDAMAGNA, Ornella
 Distribuzione geografica
Continente #
NA - Nord America 4.713
EU - Europa 3.552
AS - Asia 1.881
SA - Sud America 47
AF - Africa 35
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 10.255
Nazione #
US - Stati Uniti d'America 4.630
CN - Cina 964
IT - Italia 617
SG - Singapore 493
IE - Irlanda 470
SE - Svezia 467
DE - Germania 419
FR - Francia 356
UA - Ucraina 285
FI - Finlandia 268
KR - Corea 229
GB - Regno Unito 158
GR - Grecia 103
PL - Polonia 103
AT - Austria 101
RU - Federazione Russa 89
CA - Canada 63
VN - Vietnam 57
IN - India 31
BR - Brasile 27
BE - Belgio 24
TH - Thailandia 22
ES - Italia 21
ID - Indonesia 20
MX - Messico 19
NL - Olanda 15
JP - Giappone 14
AU - Australia 13
CH - Svizzera 11
CO - Colombia 11
EU - Europa 11
MU - Mauritius 9
IR - Iran 8
NO - Norvegia 7
RO - Romania 7
BG - Bulgaria 6
NG - Nigeria 6
TW - Taiwan 6
HK - Hong Kong 5
TR - Turchia 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
IL - Israele 4
PH - Filippine 4
PT - Portogallo 4
RS - Serbia 4
CM - Camerun 3
EG - Egitto 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SN - Senegal 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BF - Burkina Faso 2
BH - Bahrain 2
DK - Danimarca 2
EE - Estonia 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
CI - Costa d'Avorio 1
CL - Cile 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TN - Tunisia 1
ZM - Zambia 1
Totale 10.255
Città #
Chandler 670
Beijing 628
Dublin 469
Santa Clara 413
Singapore 401
Houston 264
Villeurbanne 237
Princeton 197
Medford 188
Jacksonville 186
Ann Arbor 163
Ashburn 141
Columbus 127
Fairfield 122
Wilmington 122
Dearborn 93
Vienna 83
Warsaw 80
Torino 76
Woodbridge 75
Hefei 70
Milan 62
Nyköping 58
Fremont 55
Cambridge 54
Guangzhou 46
Boardman 45
West Jordan 40
Rome 38
Seattle 37
Nanchang 35
Boston 34
Verona 34
Toronto 31
Dong Ket 30
Falls Church 27
Redwood City 26
Kennett Square 25
Pisa 24
Nanjing 22
Brussels 20
Düsseldorf 20
Athens 19
Hebei 17
Lachine 17
Salt Lake City 17
Norwalk 16
Jinan 15
Turin 15
Hangzhou 13
Jakarta 12
San Diego 12
Kunming 11
Avellino 10
Munich 10
Naples 10
San Mateo 10
Taizhou 10
Wuhan 8
Zhengzhou 8
Bengaluru 7
Chengdu 7
Graz 7
Pune 7
Shanghai 7
São Paulo 7
Toledo 7
Bari 6
Mariano Comense 6
Mountain View 6
Nanning 6
New York 6
Tokyo 6
Catanzaro 5
Chicago 5
Des Moines 5
Duncan 5
Florence 5
Ivrea 5
Medellín 5
Phoenix 5
Shenyang 5
Silver Spring 5
Southend 5
Trezzano Sul Naviglio 5
Veracruz 5
Washington 5
Baotou 4
Belfast 4
Bolzano 4
Borgaro Torinese 4
Bucharest 4
Changsha 4
Florianópolis 4
Gwanak-gu 4
Helsinki 4
Latina 4
Los Angeles 4
Milazzo 4
Moscow 4
Totale 6.005
Nome #
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 478
Alimentazione e prevenzione del rischio cardiovascolare 339
Serum lipid profile and fatty acid composition of erythrocyte phospholipids in children and adolescents with primary hyperlipidemia 242
Lysosomal acid lipase deficiency – An under-recognized cause of dyslipidaemia and liver dysfunction 231
Cardiovascular risk in children: apoB/apoA1 and non-HDL-cholesterol 187
A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia. 160
Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children 160
Effects of lycopene supplementation on oxidative stess in children affected by primary dyslipidemia. 136
Impact of nutrition since early life on cardiovascular prevention. 134
Cholesteryl ester storage disese: experiences in pediatrics 133
Diagnostic and clinical aspects of children affected by primary dyslipidemia. 126
Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants 126
Identification and management of dyslipidemic children 125
The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols 121
Correlation between intima media thickness measurement and biochemical markers of atherosclerosis in childhood 114
Usefulness of intima media thickness, ApoB and nonHDL-C in primary dislipidemic children. 111
Bifidobacteria supplementation: Effects on plasma lipid profiles in dyslipidemic children 106
HDL-C profile and BMI in dyslipidemic children. 102
A new mutation of apo av in severe hypertriglyceridemia 102
L'alimentazione del bambino e la prevenzione del rischio cardiovascolare. 101
The impact of familial hypobetalipoproteinemia in liver steatosis 99
Il rischio cardiovascolare nel bambino affetto da dislipidemia primitiva. 98
Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene 96
A new mutation of the apolipoprotein B gene originates the apo B32,4 truncated protein. 95
Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia 93
Diet in the treatment of familial combined hyperlipidemia in children 93
The treatment of hypercholesterolemic children: Efficacy and safety of a combination of red yeast rice extract and policosanols 93
Convulsive crisis in the young infant. Incidence of febrile convulsions in a an extensive case load over a period of years. 92
ApoB AND NON-HDL-CHOLESTEROL: CARDIOVASCULAR RISK FACTORS IN CHILDREN 92
A Novel Loss of Function Mutation of PCSK9 Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol 90
Le dislipidemie in pediatria 87
L'importanza della diagnosi del bambino affetto da dislipidemia primitiva 87
A novel loss of function mutation of PCSK9 gene in caucasians with low plasma LDL-cholesterol. 87
Apolipoprotein E allele frequencies in familial combined hyperlipidemia Italian families 87
Trattamento neonatale della malattia delle urine a sciroppo d'acero (MSUD) 86
La prevenzione cardiovascolare nel bambino e nell’adolescente: Ruolo della colesterolemia. 85
The Treatment of Colesteryl Storage Disease (CESD) by Ezetimibe Monotherapy. 85
Natural History Study of Early Onset Lysosomal Acid Lipase (lal) Deficiency (wolman Disease) Confirms a Severe and Rapid Disease Course 84
Lipoprotein(a) and Family History of Cardiovascular Disease in Children with Familial Dyslipidemias. 84
X-linked ectodermal dysplasia. Presentation of 2 cases. 83
Heterogeneity of the MELAS 3243 mutation 83
Echographic evaluation of vascular damage in a cohort of dyslipemic children. 83
Bethanechol versus antiacids in the treatment of gastroesophageal reflux. 80
The diagnosis of inherited dislipidenhas in children 78
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease 78
“Does apolipoprotein E (Apo E) epsilon 4 allele modulate the familial combined hyperlipidemia expression?” 78
Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption. 77
Screening neonatale di massa per malattie metaboliche: 10 anni di attività nella regione Piemonte 77
Impact of apo E genotype on familial combined hyperlipemia (FCHL) expression 76
Artery wall B-mode ultrasound measurment in hyperlipidemic children. 76
Could dyslipidemic children benefit from glucomannan intake? 75
Catalytic activity of tetrahydrobiopterin in dihydropteridine reductase deficiency and indications for treatment. 74
Prenatal diagnosis in primary hyperphenylalaninemias. 74
Inherited dyslipemias are disorders affecting children? 72
Familial hypobetalipoproteinemia and liver steatosis. 72
Clinical Features of Lysosomal Acid Lipase Deficiency 72
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 72
Per i bambini giusto nutrimento ed esercizio. Non troppo e non troppo poco 71
EFFECTS OF LYCOPENE SUPPLEMENTATION ON OXIDATIVE STRESSS IN CHILDREN AFFECTED BY PRIMARY DYSLIPIDEMIA 71
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 71
Attempt of Indirect Screening of Tetrahydrobiopterin Deficiencies. 70
Familial combined hyperlipemia in childhood 69
Impaired lipid transport due to heterozygous hypobetalipoproteinemia. 69
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk 69
Il trattamento non farmacologico delle dislipidemie nel bambino 68
Proteine della soia: effetti metabolici e ruolo nella prevenzione cardiovascolare. 68
Influence of diet on lipoprotein profile in familial combined hyperlipidemia affected children 67
The diagnosis of inherited dislipidemias in children. 67
Isolated Hyperlipoprotein(a) in children with familial cardiovascular events. 66
Antenatal Diagnosis of Tetrahydrobiopterin Deficiency by Quantification. 66
P-selectin levels in children affected by dyslipidemia. 65
Selective screening of genetic dislipemias in Italian children. 65
Prevenzione e screening delle dislipidemie primitive nel bambino: verso un nuovo approccio? 64
Familial Hypobetalipoproteinemia and liver steatosis. 64
Serum levels of IgA and celiac disease. Case reports. 63
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 63
LDL Receptor gene mutation in italian children affected by familial hypercholesterolemia. 63
The inflammation biomarkers correlate with intima-media thickness in dyslipemic children. 63
Mediterranean Dietary Treatment in Hyperlipidemic Children: Should It Be an Option? 63
The clinical score for diagnosis of bronchiolitis in sucklings. Retrospective checking of 133 cases (1974-1981). 62
Dihydropteridine reductase activity in fetal tissues 62
Liver steatosis and familial hypobetalipoproteinemia due to new apolipoprotein B truncated proteins 61
LDL receptor gene mutations and lipid pattern in Italian children affected by familial hypercholesterolemia 61
Two mutations of Dihydropteridine Reductase Deficiency. 61
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 60
Identification of a MELAS patient presenting as intestinal occlusion 59
Evaluation of the intima-media thickness in familial combined hyperlipemia. 59
Phytosterols Therapy in Children. 57
Prenatal-Diagnosis of Tetrahydrobiopterin Deficiency 56
Fate of peripherally administered tetrahydrobiopterin in congenital tetrahydrobiopterin deficiency 56
Progression of 6-pyruvoyl-tetrahydropterin synthase deficiency from a peripheral into a central phenotype. 55
The familial hypercholesterolemia in Italian children. 55
Selective Screening of genetic dyslipidemias in italian children. 55
Placental barrier in mother-to-fetus transfer of tetrahydrobiopterin in humans 54
Unusual case of atypic PKU: peripheral or central formo f PPH4S deficiency? 54
Molecular Testing of Families with Ornithine Transcarbamylase (OTC) Deficiency 54
Rapid detection of medium chain acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels. 53
A novel loss of function mutation of PCSK9 gene 53
Lipoprotein(a) and Family History of Cardiovascular Disease in Children. 50
Genotype-phenotype correlations in ornithine-transcarbamylase deficiency. 49
Totale 9.078
Categoria #
all - tutte 29.928
article - articoli 0
book - libri 0
conference - conferenze 11.674
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020810 0 0 0 0 0 0 112 64 96 88 418 32
2020/20211.134 148 85 59 54 124 55 148 60 151 71 68 111
2021/20221.277 23 22 28 98 66 27 78 82 58 121 324 350
2022/20231.966 255 132 65 168 203 488 164 128 218 29 69 47
2023/2024673 106 114 44 43 32 48 11 38 7 61 42 127
2024/20251.165 10 78 42 175 749 111 0 0 0 0 0 0
Totale 10.642